Results overview: Found 22 records in 0.02 seconds.
Articles, 22 records found
Articles 22 records found  1 - 10nextend  jump to record:
1.
2 p, 536.6 KB Correction to : Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, Denmark / Ali, M. Sanni (Saint Paul Hospital Millennium Medical College. Department of Public Health) ; Ernst, Martin (University of Southern Denmark. Department of Public Health, Clinical Pharmacology and Pharmacy) ; Robinson, Danielle E. (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Caskey, Fergus (University of Bristol. Population Health Sciences) ; Arden, Nigel K. (MRC Lifecourse Epidemiology Unit) ; Ben-Shlomo, Yoav (University of Bristol. Population Health Sciences) ; Nybo, Mads (Odense University Hospital (Dinamarca)) ; Rubin, Katrine H. (University of Southern Denmark. Department of Health) ; Judge, Andrew (MRC Lifecourse Epidemiology Unit) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit) ; Javaid, M. K. (MRC Lifecourse Epidemiology Unit) ; Hermann, Anne P. (Odense University Hospital (Dinamarca)) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Universitat Autònoma de Barcelona
2021 - 10.1007/s11657-021-01001-9
Archives of Osteoporosis, Vol. 16 (september 2021)  
2.
11 p, 810.9 KB The treatment gap after major osteoporotic fractures in Denmark 2005-2014 : a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications / Skjødt, M. K. (Holbæk Hospital (Dinamarca)) ; Ernst, M. T. (University of Southern Denmark. Department of Public Health, Clinical Pharmacology, Pharmacy and Environmental Medicine) ; Khalid, S. (Oxford University Hospitals. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Libanati, C. (UCB Pharma) ; Cooper, Cyrus (University of Southampton) ; Delmestri, Antonella (Oxford University Hospitals. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Rubin, K. H. (University of Southern Denmark) ; Javaid, M. K. (Oxford University Hospitals. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Martínez-Laguna, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Prieto-Alhambra, D. (Oxford University Hospitals. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Abrahamsen, Bo (Oxford University Hospitals. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Universitat Autònoma de Barcelona
This study demonstrates a substantial and persistent anti-osteoporosis treatment gap in men and women ≥50 years old who sustained major osteoporotic fracture(s) between 2005 and 2014 in Denmark. This was not substantially reduced by including hospital-administered anti-osteoporosis treatments. [...]
2021 - 10.1007/s00198-021-05890-x
Osteoporosis International, Vol. 32 (march 2021) , p. 1961-1971  
3.
12 p, 944.6 KB Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease : an open cohort multivariable and propensity score analysis from Funen, Denmark / Ali, M. Sanni (London School of Hygiene and Tropical Medicine. Department of Non-communicable Disease Epidemiology) ; Ernst, Martin (University of Southern Denmark. Department of Public Health, Clinical Pharmacology and Pharmacy) ; Robinson, Danielle E. (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Caskey, Fergus (University of Bristol. Population Health Sciences) ; Arden, Nigel K. (MRC Lifecourse Epidemiology Unit) ; Ben-Shlomo, Yoav (University of Bristol. Population Health Sciences) ; Nybo, Mads (Odense University Hospital (Dinamarca)) ; Rubin, Katrine H. (University of Southern Denmark. Department of Health) ; Judge, Andrew (MRC Lifecourse Epidemiology Unit) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit) ; Javaid, M. K. (MRC Lifecourse Epidemiology Unit) ; Hermann, Anne P. (Odense University Hospital (Dinamarca)) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Universitat Autònoma de Barcelona
Bisphosphonates are contraindicated in moderate-to-severe chronic kidney disease patients. However, they are used to prevent fragility fractures in patients with impaired kidney function, despite a lack of evidence on their effects on bone density in these patients. [...]
2020 - 10.1007/s11657-020-00746-z
Archives of Osteoporosis, Vol. 15 (june 2020)  
4.
8 p, 535.7 KB The impact of rheumatoid arthritis on the risk of adverse events following joint replacement : a real-world cohort study / Burn, Edward (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK) ; Edwards, Christopher J (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Murray, David W (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK) ; Silman, Alan (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit, Southampton University, Southampton, UK) ; Arden, Nigel K (MRC Lifecourse Epidemiology Unit, Southampton University, Southampton, UK) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Pinedo-Villanueva, Rafael (MRC Lifecourse Epidemiology Unit, Southampton University, Southampton, UK) ; Universitat Autònoma de Barcelona
To assess whether rheumatoid arthritis (RA) is associated with a greater risk of adverse events following total knee replacement (TKR) and total hip replacement (THR) than osteoarthritis (OA). Individuals with a diagnosis of RA or OA were identified using primary care records. [...]
2018 - 10.2147/CLEP.S160347
Clinical Epidemiology, Vol. 10 (june 2018) , p. 697-704  
5.
16 p, 967.2 KB Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs / Fuggle, N. R. (University of Southampton) ; Cooper, Cyrus (University of Oxford) ; Harvey, N. C. (University of Southampton) ; Al-Daghri, Nasser (King Saud University) ; Brandi, M.-L. (University Hospital of Florence) ; Bruyere, O. (WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium) ; Cano, A. (University of Valencia) ; Dennison, E. M. (University of Southampton) ; Diez-Perez, A. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Kaufman, J.-M. (Universitair Ziekenhuis Gent) ; Palacios, S. (The Palacios Institute of Women's Health, Madrid) ; Prieto-Alhambra, D. (University of Oxford) ; Rozenberg, S. (CHU St Pierre, Bruxelles) ; Thomas, T. (CHU de Saint-Etienne, France) ; Tremollieres, F. (Toulouse University Hospital) ; Rizzoli, R. (Hôpitaux Universitaires Genève) ; Kanis, J. A. (Australian Catholic University) ; Reginster, J. Y. (King Saud University) ; Universitat Autònoma de Barcelona
The incidence of osteoporosis and cardiovascular disease increases with age, and there are potentially shared mechanistic associations between the two conditions. It is therefore highly relevant to understand the cardiovascular implications of osteoporosis medications. [...]
2020 - 10.1007/s40265-020-01364-2
Drugs, Vol. 80 (july 2020) , p. 1537-1552  
6.
10 p, 780.0 KB Secular trends in the initiation of therapy in secondary fracture prevention in Europe : a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom / Skjødt, M. K. (Odense University Hospital (Dinamarca)) ; Khalid, S. (Oxford University Hospitals. Nuffield Orthopaedic Centre) ; Ernst, M. (University of Southern Denmark. Department of Public Health, Clinical Pharmacology and Pharmacy) ; Rubin, K. H. (Odense University Hospital (Dinamarca)) ; Martínez-Laguna, Daniel (Universitat Autònoma de Barcelona. Departament de Medicina) ; Delmestri, Antonella (Oxford University Hospitals. Nuffield Orthopaedic Centre) ; Javaid, M. K. (Oxford University Hospitals. Nuffield Orthopaedic Centre) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, England) ; Libanati, C. (UCB Pharma) ; Toth, E. (UCB Pharma) ; Abrahamsen, Bo (Oxford University Hospitals. Nuffield Orthopaedic Centre) ; Prieto-Alhambra, Daniel (Oxford University Hospitals. Nuffield Orthopaedic Centre)
This paper demonstrates a large post-fracture anti-osteoporosis treatment gap in the period 2005 to 2015. The gap was stable in Denmark at around 88-90%, increased in Catalonia from 80 to 88%, and started to increase in the UK towards the end of our study. [...]
2020 - 10.1007/s00198-020-05358-4
Osteoporosis International, Vol. 31 (march 2020) , p. 1535-1544  
7.
15 p, 1.4 MB Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data : a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database / Khalid, Sara (Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom) ; Calderon-Larrañaga, Sara (Family and Community Medicine Teaching Unit of Granada. Cartuja University Health Centre. Andalusian Health Service (SAS), Granada, Spain) ; Hawley, Samuel (Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom) ; Ali, M Sanni (London School of Hygiene and Tropical Medicine, London, United Kingdom) ; Judge, Andrew (Bristol NIHR Biomedical Research Centre (Bristol, Regne Unit)) ; Arden, Nigel (University of Oxford. Arthritis Research UK Centre for Sport, Exercise, and Osteoarthritis) ; van Staa, Tjeerd (Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands) ; Cooper, Cyrus (NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom) ; Javaid, Muhammad Kassim (Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom) ; Prieto-Alhambra, Daniel (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Universitat Autònoma de Barcelona
This paper aims to compare the clinical effectiveness of oral anti-osteoporosis drugs based on the observed risk of fracture while on treatment in primary care actual practice. We investigated two primary care records databases covering UK National Health Service (Clinical Practice Research Datalink, CPRD) and Catalan healthcare (Information System for Research in Primary Care, SIDIAP) patients during 1995-2014 and 2006-2014, respectivey. [...]
2018 - 10.2147/CLEP.S164112
Clinical Epidemiology, Vol. 10 (october 2018) , p. 1417-1431  
8.
8 p, 2.2 MB Prevalence and Mortality of Individuals With X-Linked Hypophosphatemia : A United Kingdom Real-World Data Analysis / Hawley, Samuel (University of Oxford. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences) ; Shaw, Nick J (Institute of Metabolism & Systems Research, University of Birmingham) ; Delmestri, Antonella (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford) ; Prieto-Alhambra, Daniel (Universitat Autònoma de Barcelona) ; Cooper, Cyrus (MRC Lifecourse Epidemiology Unit, University of Southampton) ; Pinedo-Villanueva, Rafael (Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford) ; Javaid, M Kassim (MRC Lifecourse Epidemiology Unit, University of Southampton)
X-linked hypophosphatemia (XLH) is a rare multisystemic disease with a prominent musculoskeletal phenotype. We aim here to improve understanding of the prevalence of XLH across the life course and of overall survival among people with XLH. [...]
2020 - 10.1210/clinem/dgz203
The Journal of Clinical Endocrinology and Metabolism, Vol. 105 Num. 3 (March 2020)  
9.
12 p, 639.3 KB Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures / Kanis, J. A. (Australian Catholic University. Mary McKillop Health Institute) ; Harvey, N. C. (University of Southampton. MRC Lifecourse Epidemiology Unit) ; McCloskey, E. (MRC and Arthritis Research UK Centre for Integrated Research in Musculoskeletal Ageing Mellanby) ; Bruyère, O. (University of Liège. World Health Organization Collaborating Center for the Public Health Aspects of Musculoskeletal Health and Aging, Department of Public Health, Epidemiology and Health Economics) ; Veronese, N. (Neuroscience Institute (Pàdua, Itàlia). Aging Branch) ; Lorentzon, M. (Sahlgrenska University Hospital (Suècia)) ; Cooper, Cyrus (University of Oxford. NIHR Musculoskeletal Biomedical Research Unit) ; Rizzoli, R. (Geneva University Hospitals (Suïssa)) ; Adib, G. (Syrian National Osteoporosis Society) ; Al-Daghri, Nasser (King Saud University. Chair for Biomarkers of Chronic Diseases, Biochemistry Dept., College of Science) ; Campusano, C. (Universidad de los Andes. Clinica Universidad de los Andes and Faculty of Medicine) ; Chandran, M. (Singapore General Hospital, ACADEMIA. Osteoporosis and Bone Metabolism Unit, Department of Endocrinology) ; Dawson-Hughes, Bess (Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University) ; Javaid, K. (University of Oxford. NIHR Musculoskeletal Biomedical Research Unit) ; Jiwa, F. (Osteoporosis Canada. Chair of the Committee of Patients Societies at the International Osteoporosis Foundation) ; Johansson, H. (Australian Catholic University. Mary McKillop Health Institute) ; Lee, J. K. (Beacon International Specialist Centre, Petaling Jaya, Malaysia) ; Liu, E. (Australian Catholic University. Mary McKillop Health Institute) ; Messina, D. (Cosme Argerich. IRO Medical Research Center, Buenos Aires and Rheumatology section) ; Mkinsi, O. (Ibn Rochd University Hospital. Department of Rheumatology) ; Pinto, D. (Northwestern University. Department of Medical Social Sciences, Feinberg School of Medicine) ; Prieto-Alhambra, Daniel (Universitat Autònoma de Barcelona) ; Saag, K. (University of Alabama at Birmingham) ; Xia, W. (Chinese Academy of Medical Sciences & Peking Union Medical College. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital) ; Zakraoui, L. (University Tunis Manar and Hôpital Mongi-Slim. Service de Rhumatologie) ; Reginster, J. -Y. (University of Liège. Department of Public Health, Epidemiology and Health Economics)
Guidance is provided in an international setting on the assessment and specific treatment of postmenopausal women at low, high and very high risk of fragility fractures. The International Osteoporosis Foundation and European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis published guidance for the diagnosis and management of osteoporosis in 2019. [...]
2020 - 10.1007/s00198-019-05176-3
Osteoporosis International, Vol. 31 (2020) , p. 1-12  
10.
15 p, 1.0 MB Radiofrequency echographic multi-spectrometry for the in-vivo assessment of bone strength : state of the art-outcomes of an expert consensus meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) / Díez Pérez, Adolfo (Universitat Autònoma de Barcelona. Departament de Medicina) ; Brandi, Maria Luisa (University of Florence. Department of Biological, Experimental and Clinical Science) ; Al-Daghri, Nasser (King Saud University. Chair for Biomarkers of Chronic Diseases, Biochemistry Department, College of Science) ; Branco, Jaime C. (Universidade Nova de Lisboa. NOVA Medical School) ; Bruyère, Olivier (Université de Liège) ; Cavalli, Loredana (University of Florence. Department of Biological, Experimental and Clinical Science) ; Cooper, Cyrus (University of Southampton. MRC Lifecourse Epidemiology Unit, Southampton General Hospital) ; Cortet, Bernard (University Hospital of Lille (França)) ; Dawson-Hughes, Bess (Tufts University. Bone Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging) ; Dimai, Hans Peter (Medical University of Graz. Department of Internal Medicine, Division of Endocrinology and Diabetology) ; Gonnelli, Stefano (University of Siena. Department of Medicine, Surgery and Neurosciences) ; Hadji, Peyman (Frankfurter Hormon und Osteoporose Zentrum, Frankfurt, Germany) ; Halbout, Philippe (International Osteoporosis Foundation, Nyon, Switzerland) ; Kaufman, Jean-Marc (Universitair Ziekenhuis Gent) ; Kurth, Andreas (Mayor Teaching Hospital, Charite Medical School) ; Locquet, Medea (University of Liège. Department of Public Health, Epidemiology and Health Economics) ; Maggi, Stefania (Institute of Neuroscience. National Research Council, Aging Program) ; Matijevic, Radmila (Clinical Center of Vojvodina, Clinic for Orthopedic Surgery) ; Reginster, Jean-Yves (Université de Liège) ; Rizzoli, René (Geneva University Hospitals (Suïssa)) ; Thierry, Thomas (University of Lyon. INSERM 1059)
The purpose of this paper was to review the available approaches for bone strength assessment, osteoporosis diagnosis and fracture risk prediction, and to provide insights into radiofrequency echographic multi spectrometry (REMS), a non-ionizing axial skeleton technique. [...]
2019 - 10.1007/s40520-019-01294-4
Aging Clinical and Experimental Research, Vol. 31 (august 2019) , p. 1375-1389  

Articles : 22 records found   1 - 10nextend  jump to record:
See also: similar author names
4 Cooper, C.
1 Cooper, C.S.
1 Cooper, Colin
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.